Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies-Reference-Cited by-同舟云学术

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

Published:2021-05 Issue:4 Volume:14 Page:1566-1577
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Bloem Lourens T.¹²,Vreman Rick A.¹³,Peeters Niels W. L.¹,Hoekman Jarno¹⁴,Elst Menno E.²,Leufkens Hubert G. M.¹,Klungel Olaf H.¹⁵,Goettsch Wim G.³,Mantel‐Teeuwisse Aukje K.¹

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht The Netherlands

2. Dutch Medicines Evaluation Board Utrecht The Netherlands

3. National Healthcare Institute Diemen The Netherlands

4. Innovation Studies, Copernicus Institute of Sustainable Development Utrecht University Utrecht The Netherlands

5. Faculty of Health Sciences University of Southern Denmark Odense Denmark

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13027

Reference46 articles.

1. Comparing access to orphan medicinal products in Europe